INSD.US Instadose Pharma Corp
- Market cap
- USD 53.2K
- P/E
- -
- P/B
- 0.02x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Feb 2022.
Is INSD.US undervalued?
Graham numberThe Graham number of Instadose Pharma Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Instadose Pharma Corp fundamental analysis
No fundamental analysis for Instadose Pharma Corp yet.
Instadose Pharma Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Instadose Pharma Corp
Instadose Pharma Corp. engages in growing, cultivation, processing, and global distribution of medical-grade cannabinoid oil. The company was founded in 2017 and is based in Burlington, Canada.
Full company profileInstadose Pharma Corp financial statements
2022 annualized: Fiscal year 2022 is not finished. Income statement and cash flow are annualized from 1 quarter up to Feb 28, 2022, the balance sheet is the latest quarter. Figures change when the annual report is published.
Instadose Pharma Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 0.00 | 2.72K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | - | 1.33K | 0.00 | 0.00 | - | - |
| Operating Income | -31.9K | -23.5K | -23.3K | -25.7K | 462K | 2.30M |
| EBITDA | - | - | - | - | -462K | -2.57M |
| Net Income | -31.9K | -23.5K | -23.3K | -25.7K | -462K | -1.40M |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 |
| Balance Sheet | ||||||
| Total Assets | 1.09K | 100.00 | 0.00 | 65.00 | 0.00 | 45.9M |
| Total Liabilities | 13.1K | 33.5K | 56.7K | 82.4K | 162K | 162K |
| Shareholders' Equity | -12.0K | -33.4K | -56.7K | -82.4K | -162K | -162K |
| Cash & Short-term Investments | 1.09K | 100.00 | 0.00 | 65.00 | 0.00 | 5.33K |
| Cash Flow | ||||||
| Operating Cash Flow | -20.8K | -3.13K | -125.00 | 213.00 | -65.00 | 642K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -20.8K | -3.13K | -125.00 | 213.00 | -65.00 | 642K |
| Ratios | ||||||
| ROA | -2,941.7% | -23,540.0% | - | -39,472.3% | - | -3.0% |
| Net Profit Margin | - | -867.0% | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Instadose Pharma Corp dividends
Instadose Pharma Corp has not paid dividends in the last 5 fiscal years.
Who owns Instadose Pharma Corp
- Insiders 3.11%
- Institutions 0.00%
- Public & others 96.89%
- Shares outstanding 532M
- Free float 402M
Instadose Pharma Corp company profile
- Company name
- Instadose Pharma Corp
- Ticker
- INSD.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- November
- Address
- 5500 North Service Road, Burlington, ON, Canada, L7L 6W6
- Phone
- 905 218 3593
- Website
- instadosepharma.com
About Instadose Pharma Corp
Instadose Pharma Corp. engages in growing, cultivation, processing, and global distribution of medical-grade cannabinoid oil. The company was founded in 2017 and is based in Burlington, Canada.
Instadose Pharma Corp management
4- Mr. Grant F. SandersFounder & Executive Officer
- Mr. Lawrence M. ActonChief Operating Officer
- Mr. Loren S. Greenspoon J.D., L.L.B.Chief Legal Officer
- Mr. Antonio Rocco FranchinoCEO & Chairman